| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 347.00K | — |
| Operating expense | — | — |
| Net income | -1.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EVGN returned -57.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -49.1% |
| 1 year | -57.3% |
| 5 years | -98.1% |
| 10 years | -99.1% |
| All-time high | $196.50 (Dec 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in EVGN would be worth today ›No. Evogene Ltd. has not paid a dividend in the past 12 months.
Evogene Ltd. stock trades on NASDAQ under the ticker symbol EVGN.
Evogene Ltd. is part of the Healthcare sector.
Evogene Ltd. has a market cap of 8.89M USD, based on the latest quote.
Evogene Ltd. is expected to report earnings around Nov 19, 2026. That date is an estimate and has not been confirmed by the company.
